In the United States, FDA guidelines indicate these medications for: Adults with a BMI of 30 or higher (obesity) Adults with a BMI of 27 or higher who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea You should discuss GLP-1 medications with a physician if you have any of the following, as they may affect which medication is appropriate or require additional monitoring: Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) a contraindication for all GLP-1 drugs History of pancreatitis Kidney disease or a history of gallstones Pregnancy or plans to become pregnant History of eating disorders The Critical Factor Most People Overlook: Muscle Loss Here is something that rarely appears in GLP-1 marketing: these medications can cause significant muscle loss alongside fat loss, particularly at the aggressive weight loss rates they enable

Wegovy is available in 5 dose strengths that are introduced gradually during treatment
doi:10.1111/head.13828 Liampas I, Siokas V, Mentis AA, et al
Guest Beth shares her decades-long journey to diagnosis, her life-changing surgical experience, the role of post-op treatments (including tirzepatide), and her advocacy work with Lipedema Unfilteredoffering resources, community, and practical aftercare tips for others navigating lipoedema